journal in pedia
TRANSCRIPT
-
8/13/2019 Journal in Pedia
1/6
Brittle-Bone Babies Helped by Fetal Stem Cell Grafts
Dec. 16, 2013 Osteogeneis imperfecta (OI) is a congenital bone disease that causes
stunted growth and repeated, painful fracturing. Ultrasound scans can reveal fractures
already in the fetus, and now an international team of researchers from Sweden, Singapore
and Taiwan have treated two babies in utero by injecting bone-forming stem cells. The
longitudinal results of the treatment are published in the journal Stem Cells Translational
Medicine.
The babies were treated withmesenchymal stem cells, connective tissue cells that can form
and improve bone tissue. The stem cells were extracted from the livers of donors and
although they were completely unmatched genetically, there was no rejection and the
transplanted cells were accepted as self.
Back in 2005, a paper was published from Karolinska Institutet in Sweden describing how
stem cells were given to a female fetus. The present study describes how the girl suffered a
large number of fractures and developed scoliosis up to the age of eight, whereupon the
researchers decided to give her a fresh stem cell graft from the same donor. For the next
two years the girl suffered no new fractures and improved her growth rate. Today she
takes dance lessons and participates more in PE at school.
Another unborn baby with OI, a girl from Taiwan, was also givenstem cell
transplantation by the Karolinska Institutet team and their colleagues from Singapore. The
girl subsequently followed a normal and fracture-free growth trajectory until the age of
one, when it levelled off. She was given a fresh stem cell treatment and her growth
-
8/13/2019 Journal in Pedia
2/6
resumed. The girl started to walk and has since not suffered any new fractures. Today she
is four years old.
"We believe that the stem cells have helped to relieve the disease since none of the children
broke bones for a period following the grafts, and both increased their growth rate," says
study leader Dr Cecilia Gtherstrm, researcher at Karolinska Institutet's Department of
Clinical Sciences, Intervention and Technology. "Today, the children are doing much better
than if the transplantations had not been given. OI is a very rare disease and lacks effective
treatment, and a combined international effort is needed to examine whether stem cell
grafts can alleviate the disease."
The researchers have also identified a patient, a boy from Canada, who was born with OI
caused by exactly the same mutation as the Swedish girl had. The boy was not given
stemcell therapy and was born with severe and widespread bone damage, including
numerous fractures and kyphosis of the thoracic vertebrae, which causes such over-
curvature of the spine that it impairs breathing. The boy died of pneumonia within his first
5 months.
Journal Reference:
1. Cecilia Gtherstrm, Magnus Westgren, S W Steven Shaw, Eva strm, Arijit Biswas,Peter H Byers, Citra N Z Mattar, Gail E Graham, Jahan Taslimi, Uwe Ewald, Nicholas M
Fisk, Allen E J Yeoh, Ju-Li Lin, Po-Jen Cheng, Mahesh Choolani, Katarina Le Blanc andJerry K Y Chan. Pre and postnatal transplantation of fetal mesenchymal stem cells
in osteogenesis imperfecta: a two-center experience. Stem Cells Translational
Medicine, December 2013
-
8/13/2019 Journal in Pedia
3/6
Fetal stem cell grafts successfully help brittle-bone babiesMarie Ellis
In an international collaboration, researchers from Sweden, Singapore and Taiwan
successfully treated two babies with a congenital bone disease that causes stunted
growth and repeated fracturing by injecting them in utero with bone-forming stem
cells.
Results of their longitudinal study have been published in the journal Stem Cells
Translational Medicine.
Osteogenesis imperfecta (OI) not only stunts the growth of those who suffer from this
disease, but the repeatedfracturesit causes are painful.
However, this condition can be recognized prenatally with anultrasound,so researchers
from the Karolinska Institutet in Sweden published a paper in 2005 detailing how
mesenchymalstem cells- connective tissue cells that form and improve bone tissue - were
given to a female fetus in Sweden.
These stem cells were taken from the livers of donors, and the researchers note that
though the donors and recipients were not genetically matched, there was no
rejection.
In this recent study, the team explains how the girl experienced several fractures and
hadscoliosisby age 8. At this point, the researchers gave her a fresh stem cell graft from
the same donor as before.
For the following 2 years, the child did not experience any new fractures and her growth
rate improved. Today, the researchers say, she participates in dance lessons and gym class
at school.
http://www.medicalnewstoday.com/articles/173312.phphttp://www.medicalnewstoday.com/articles/173312.phphttp://www.medicalnewstoday.com/articles/173312.phphttp://www.medicalnewstoday.com/articles/245491.phphttp://www.medicalnewstoday.com/articles/245491.phphttp://www.medicalnewstoday.com/info/stem_cell/http://www.medicalnewstoday.com/info/stem_cell/http://www.medicalnewstoday.com/info/stem_cell/http://www.medicalnewstoday.com/articles/190940.phphttp://www.medicalnewstoday.com/articles/190940.phphttp://www.medicalnewstoday.com/articles/190940.phphttp://www.medicalnewstoday.com/articles/190940.phphttp://www.medicalnewstoday.com/info/stem_cell/http://www.medicalnewstoday.com/articles/245491.phphttp://www.medicalnewstoday.com/articles/173312.php -
8/13/2019 Journal in Pedia
4/6
-
8/13/2019 Journal in Pedia
5/6
Born with severe widespread bone damage, this boy was not given stem cell therapy like
the girls were, and he experienced numerous fractures and kyphosis of the thoracic
vertebrae - a condition that causes an extreme curvature of the spine, impairing breathing.
The untreated boy died within his first 5 months frompneumonia,the investigators say.
Although the researchers say their findings suggest the stem cell therapy treatment
"appears safe and is of likely clinical benefit," they add that "the limited experience
to date means that it is not possible to be conclusive and that further studies are
required."
http://www.medicalnewstoday.com/articles/151632.phphttp://www.medicalnewstoday.com/articles/151632.phphttp://www.medicalnewstoday.com/articles/151632.phphttp://www.medicalnewstoday.com/articles/151632.php -
8/13/2019 Journal in Pedia
6/6
I. SummaryII. ReactionIII. Recommendation